COVID-19  Vaccine Immunogenicity and Safety in ImmunoDeficient Patients

Our project’s aim is to learn more about the effectiveness, safety, and immune response in individuals with low or compromised immune systems who have been vaccinated with the Pfizer-BioNTech or Moderna mRNA or Astrazeneca COVID-19 vaccines. Interested in joining our study? We are currently recruiting the following participants from across Canada:

  • Individuals aged 12 years and older who have primary immunodeficiency (inborn error of immunity) or have been on immunotherapy for medical conditions AND:
    1. plan to be vaccinated against COVID-19, or
    2. have received their first COVID-19 vaccination, or
    3. have been fully vaccinated against COVID-19 less than 24 weeks ago
  • Anyone aged 12 years and older who has not yet been vaccinated but is planning to be vaccinated against COVID-19

Enroll Now

Our Study